DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
The inherited and familial component of early-onset colorectal cancer
Early-onset colorectal cancer (EOCRC), defined as that diagnosed before the age of 50, accounts for 10–12% of all new colorectal cancer (CRC) diagnoses. Epidemiological data indicate that EOCRC incidence is increasing, despite the observed heterogeneity among countries. Although the cause for such increase remains obscure, ≈13% (range: 9–26%) of EOCRC patients carry pathogenic germline variants in known cancer predisposition genes, including 2.5% of patients with germline pathogenic variants in hereditary cancer genes traditionally not associated with CRC predisposition. Approximately 28% of EOCRC patients have family history of the disease. This article recapitulates current evidence on the inherited syndromes that predispose to EOCRC and its familial component. The evidence gathered support that all patients diagnosed with an EOCRC should be referred to a specialized genetic counseling service and offered somatic and germline pancancer multigene panel testing. The identification of a germline pathogenic variant in a known hereditary cancer gene has relevant implications for the clinical management of the patient and his/her relatives, and it may guide surgical and therapeutic decisions. The relative high prevalence of hereditary cancer syndromes and familial component among EOCRC patients supports further research that helps understand the genetic background, either monogenic or polygenic, behind this increasingly common disease., Laura Valle’s group receives funding from the Spanish Ministry of Science and Innovation,
co-funded by FEDER funds [SAF2016-80888-R and predoctoral fellowship to IQ]; Instituto de Salud
Carlos III [CIBERONC CB16/12/00234 and Sara Borrell contract (PM)]; Government of Catalonia
[AGAUR 2017SGR1282, CERCA Program]; Fundación Olga Torres; and Scientific Foundation Asociación
Española Contra el Cáncer [AECC Investigador contract (MT)]. Francesc Balaguer’s group receives
funding from the Instituto de Salud Carlos III, cofunded by FEDER funds [PI16/00766; PI19/01867].
This study was facilitated by COST Action CA17118, supported by COST (European Cooperation in
Science and Technology).
Project:
MINECO SAF2016-80888-R
View at: http://hdl.handle.net/10261/260406